Paper41007442
Induction of Sustained Immunity Following Vaccination with Live Attenuated Trypanosoma cruzi Parasites Combined with Saponin-Based Adjuvants.
Zabala BA and 8 others. Biology (Basel), 2025. Cited by 2 papers, by iCite.
Cite this record
ConductScience Library. Induction of Sustained Immunity Following Vaccination with Live Attenuated Trypanosoma cruzi Parasites Combined with Saponin-Based Adjuvants. Papers, record 41007442. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41007442
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Induction of Sustained Immunity Following Vaccination with Live Attenuated Trypanosoma cruzi Parasites Combined with Saponin-Based Adjuvants.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
Grants4
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| 2017 | Fundacion Florencio Fiorini | PubMed | PubMed | ||
| 2016 | Bunge & Born Foundation | PubMed | PubMed | ||
| PICT 2018-3082 | Agencia Nacional de Promocion Cientifica y Tecnica | PubMed | PubMed | ||
| PIBBA 28720210100607 | Consejo Nacional de Investigaciones Científicas y Técnicas | PIBBA287202 | PubMed | NIH RePORTER |
References55
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 27634183 | An Updated Review of ISCOMSTM and ISCOMATRIXTM Vaccines. | Curr Pharm Des | 2016 | https://conductscience.org/library/papers/27634183 | PubMed |
| 2 | 38481660 | Vaccination with parasite-specific TcTASV proteins combined with recombinant baculovirus as a delivery platform protects against acute and chronic Trypanosoma cruzi infection. | Front Cell Infect Microbiol | 2024 | https://conductscience.org/library/papers/38481660 | PubMed |
| 3 | 29578409 | Spontaneous dormancy protects Trypanosoma cruzi during extended drug exposure. | Elife | 2018 | https://conductscience.org/library/papers/29578409 | PubMed |
| 4 | 22705838 | Genetically attenuated Trypanosoma cruzi parasites as a potential vaccination tool. | Bioengineered | 2012 | https://conductscience.org/library/papers/22705838 | PubMed |
| 5 | 29601585 | Trypanosoma cruzi 80 kDa prolyl oligopeptidase (Tc80) as a novel immunogen for Chagas disease vaccine. | PLoS Negl Trop Dis | 2018 | https://conductscience.org/library/papers/29601585 | PubMed |
| 6 | 25921214 | CD8+ T cells in Trypanosoma cruzi infection. | Semin Immunopathol | 2015 | https://conductscience.org/library/papers/25921214 | PubMed |
| 7 | 39460337 | Intranasal Trans-Sialidase Vaccine Mitigates Acute and Chronic Pathology in a Preclinical Oral Chagas Disease Model. | Vaccines (Basel) | 2024 | https://conductscience.org/library/papers/39460337 | PubMed |
| 8 | 32464684 | Recombinant Mycobacterium bovis BCG is a promising platform to develop vaccines against Trypansoma cruzi infection. | Clin Exp Immunol | 2020 | https://conductscience.org/library/papers/32464684 | PubMed |
| 9 | 9934965 | Levels of tumor necrosis factor alpha, gamma interferon, and interleukins 4,6, and 10 as determined in mice infected with virulent or attenuated strains of Trypanosoma cruzi. | Parasitol Res | 1999 | https://conductscience.org/library/papers/9934965 | PubMed |
| 10 | 24551259 | A monoallelic deletion of the TcCRT gene increases the attenuation of a cultured Trypanosoma cruzi strain, protecting against an in vivo virulent challenge. | PLoS Negl Trop Dis | 2014 | https://conductscience.org/library/papers/24551259 | PubMed |
| 11 | 14604574 | Use of a purified Trypanosoma cruzi antigen and CpG oligodeoxynucleotides for immunoprotection against a lethal challenge with trypomastigotes. | Vaccine | 2003 | https://conductscience.org/library/papers/14604574 | PubMed |
| 12 | 25853654 | Immune protection against Trypanosoma cruzi induced by TcVac4 in a canine model. | PLoS Negl Trop Dis | 2015 | https://conductscience.org/library/papers/25853654 | PubMed |
| 13 | 19381287 | Accurate real-time PCR strategy for monitoring bloodstream parasitic loads in chagas disease patients. | PLoS Negl Trop Dis | 2009 | https://conductscience.org/library/papers/19381287 | PubMed |
| 14 | 35279330 | Nasal immunization with a L. lactis-derived trans-sialidase antigen plus c-di-AMP protects against acute oral T. cruzi infection. | Vaccine | 2022 | https://conductscience.org/library/papers/35279330 | PubMed |
| 15 | 31116244 | Evaluation of pathogen P21 protein as a potential modulator of the protective immunity induced by Trypanosoma cruzi attenuated parasites. | Mem Inst Oswaldo Cruz | 2019 | https://conductscience.org/library/papers/31116244 | PubMed |
| 16 | 11228380 | QS-21 promotes an adjuvant effect allowing for reduced antigen dose during HIV-1 envelope subunit immunization in humans. | Vaccine | 2001 | https://conductscience.org/library/papers/11228380 | PubMed |
| 17 | 25496192 | Gene-deleted live-attenuated Trypanosoma cruzi parasites as vaccines to protect against Chagas disease. | Expert Rev Vaccines | 2015 | https://conductscience.org/library/papers/25496192 | PubMed |
| 18 | 38612650 | Chagas Disease: A Silent Threat for Dogs and Humans. | Int J Mol Sci | 2024 | https://conductscience.org/library/papers/38612650 | PubMed |
| 19 | 3111281 | Field trial of vaccination against American trypanosomiasis (Chagas' disease) in domestic guinea pigs. | Am J Trop Med Hyg | 1987 | https://conductscience.org/library/papers/3111281 | PubMed |
| 20 | 16556475 | Acylated and deacylated saponins of Quillaja saponaria mixture as adjuvants for the FML-vaccine against visceral leishmaniasis. | Vaccine | 2006 | https://conductscience.org/library/papers/16556475 | PubMed |
Cited by2
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 2 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42347647 | Long-Lasting Antibody and CD8+ Memory T Cell Responses Induced by N-Tc52/TSKb20 Vaccination upon Trypanosoma cruzi Antigen Re-Encounter. | Vaccines (Basel) | 2026 | https://conductscience.org/library/papers/42347647 | PubMed |
| 41893765 | Immunoproteomic Identification and Vaccine Assessment of Trypanosoma vivax Invariant Surface Glycoprotein. | Vaccines (Basel) | 2026 | https://conductscience.org/library/papers/41893765 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41007442
GET https://conductscience.org/api/papers/v1/41007442/references?page=2